Article Details

JHBP CY : Genor BioPharma announced IND application of GB492 is under NMPA review

Retrieved on: 2021-03-12 12:22:30

Tags for this article:

Click the tags to see associated articles and topics

JHBP CY : Genor BioPharma announced IND application of GB492 is under NMPA review. View article details on hiswai:

Excerpt

SHANGHAI, China, March 12, 2021 -- Genor Biopharma (Stock code: 6998.HK) announced today IND application of GB492 (IMSA101, Stimulator of ...

Article found on: www.marketscreener.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up